Quick Answer
Ernexa Therapeutics Inc. reported Common Stock Shares Outstanding of 7.85 million shares for the year ending 2025.
- Ernexa Therapeutics Inc. showed an increase of +129.2% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Ernexa Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2010 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: 60,892 shares | Q3 2011: 60,907 shares | Q1 2012: 70,998 shares | Q2 2012: 71,045 shares | Q3 2012: 71,045 shares | Q1 2013: 71,516 shares | Q2 2013: 71,604 shares | Q3 2013: 71,773 shares | Q1 2014: 78.72 million shares | Q2 2014: 91.66 million shares | Q3 2014: 92.29 million shares | Q1 2015: 92.38 million shares | Q2 2015: 92.41 million shares | Q3 2015: 92.41 million shares | Q1 2016: 92.44 million shares | Q3 2016: 1.85 million shares | Q1 2017: 2.48 million shares | Q2 2017: 2,513 shares | Q3 2017: 2,516 shares | Q1 2018: 2.52 million shares | Q2 2018: 2.87 million shares | Q3 2018: 2.87 million shares | Q1 2019: 2.88 million shares | Q2 2019: 2,882 shares | Q3 2019: 2.90 million shares | Q1 2020: 2.93 million shares | Q2 2020: 2.94 million shares | Q3 2020: 2.95 million shares | Q1 2021: 41.51 million shares | Q2 2021: 44.71 million shares | Q3 2021: 52.04 million shares | Q1 2022: 57.45 million shares | Q2 2022: 57.47 million shares | Q3 2022: 2.94 million shares | Q1 2023: 5.13 million shares | Q2 2023: 5.41 million shares | Q3 2023: 5.41 million shares | Q1 2024: 5.41 million shares | Q2 2024: 5.41 million shares | Q3 2024: 5.41 million shares | Q1 2025: 52.25 million shares | Q2 2025: 7.48 million shares | Q3 2025: 7.85 million shares.
- Over the full 18 years of available data (2010 to 2025), Ernexa Therapeutics Inc.'s Common Stock Shares Outstanding has grown by 12,828.2%.
- Historical annual values: Fiscal year 2025: 7.85 million shares | Fiscal year 2024: 3.43 million shares | Fiscal year 2024: 51.39 million shares | Fiscal year 2023: 5.41 million shares | Fiscal year 2022: 5.13 million shares | Fiscal year 2021: 2.60 million shares | Fiscal year 2020: 0 shares | Fiscal year 2019: 2.90 million shares | Fiscal year 2018: 2.88 million shares | Fiscal year 2017: 2.52 million shares | Fiscal year 2016: 2.26 million shares | Fiscal year 2016: 92.44 million shares | Fiscal year 2015: 1.85 million shares | Fiscal year 2014: 92.37 million shares | Fiscal year 2013: 78.65 million shares | Fiscal year 2012: 71.12 million shares | Fiscal year 2011: 60,927 shares | Fiscal year 2010: 60,751 shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: